191 / 923
ith
atic
illeirs
c
,
earch
Institute,
IRCCS
of Urology, University
artment
of Radiology,
r, New York, NY, USA;
rology, LilleUniversity
jor
challenge.
It
has
)
facilitates
localisa-
gnostic accuracy
of
r of Controlled Trials
30, 2014, using
the
ND‘‘MRORNMROR
fusion weighted OR
reviewersindepen-
ethodologic quality
) 2
tool.
ad a median
age of
el
of 5.1–13.4 ng/ml
clinical
significance
t
biopsy, number
of
RI
ranged
from 44%
g prostate biopsy or
Initial Experience of 68Ga-PSMA PET/CT imaging in
High-risk Prostate Cancer Patients prior to Radical
Prostatectomy.
Budäus et al; Eur Urol (15), 2015
N=30 Patienten
12/30 mit Lymphknotenmetastasen
4 Patienten (33%) richtig positiv
8 Patienten (66,7%) als falsch negativ
Sensitivität: 33%
Spezifität: 100%
Positiv prädiktiver Wert: 100%
Negativ prädiktiver Wert: 69,2%